Gianni Colotti

4.8k total citations · 3 hit papers
99 papers, 3.3k citations indexed

About

Gianni Colotti is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Epidemiology. According to data from OpenAlex, Gianni Colotti has authored 99 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Molecular Biology, 25 papers in Public Health, Environmental and Occupational Health and 22 papers in Epidemiology. Recurrent topics in Gianni Colotti's work include Research on Leishmaniasis Studies (25 papers), Trypanosoma species research and implications (21 papers) and Microtubule and mitosis dynamics (9 papers). Gianni Colotti is often cited by papers focused on Research on Leishmaniasis Studies (25 papers), Trypanosoma species research and implications (21 papers) and Microtubule and mitosis dynamics (9 papers). Gianni Colotti collaborates with scholars based in Italy, United States and United Kingdom. Gianni Colotti's co-authors include Andrea Ilari, Annarita Fiorillo, Paola Baiocco, Francesco Fazi, Ilaria Genovese, Luciana Mosca, S. Franceschini, Emilia Chiancone, Yehuda G. Assaraf and Alberto Boffi and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Gianni Colotti

97 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Taxanes in cancer treatment: Activity, chemoresistance and its overcoming

2021 221 citations Luciana Mosca, Andrea Ilari et al. profile →
Doxorubicin and other anthracyclines in cancers: Activity, chemoresistance and its overcoming

2023 150 citations Andrea Ilari, Luciana Mosca et al. profile →
EGF receptor in organ development, tissue homeostasis and regeneration

2025 21 citations Claudia Tito, Gianni Colotti et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gianni Colotti Italy	34	1.5k	1.0k	787	656	507	99	3.3k
Lin Yang China	28	1.6k 1.1×	296 0.3×	283 0.4×	155 0.2×	340 0.7×	96	3.0k
Teck Kwang Lim Singapore	28	1.2k 0.8×	364 0.4×	292 0.4×	176 0.3×	256 0.5×	78	2.5k
Howard Kendrick United Kingdom	32	1.9k 1.3×	521 0.5×	320 0.4×	791 1.2×	1.6k 3.2×	54	3.6k
Joanna E. Burdette United States	36	2.2k 1.5×	525 0.5×	96 0.1×	299 0.5×	550 1.1×	182	4.8k
Kenneth D. Greis United States	33	2.1k 1.4×	174 0.2×	498 0.6×	490 0.7×	579 1.1×	95	3.7k
MASAKUNI OKUHARA Japan	35	3.0k 2.0×	286 0.3×	343 0.4×	1.2k 1.8×	601 1.2×	113	5.7k
Haiying Chen United States	31	2.7k 1.8×	165 0.2×	275 0.3×	670 1.0×	1.0k 2.0×	129	4.8k
Haichao Zhang United States	31	3.7k 2.5×	140 0.1×	292 0.4×	431 0.7×	1.1k 2.1×	90	5.0k
Jia Jia China	32	1.9k 1.3×	95 0.1×	371 0.5×	273 0.4×	568 1.1×	303	4.4k
Ramzi M. Mohammad United States	41	2.9k 2.0×	178 0.2×	216 0.3×	280 0.4×	1.2k 2.4×	154	4.8k

Countries citing papers authored by Gianni Colotti

Since Specialization

Citations

This map shows the geographic impact of Gianni Colotti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gianni Colotti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gianni Colotti more than expected).

Fields of papers citing papers by Gianni Colotti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gianni Colotti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gianni Colotti. The network helps show where Gianni Colotti may publish in the future.

Co-authorship network of co-authors of Gianni Colotti

This figure shows the co-authorship network connecting the top 25 collaborators of Gianni Colotti. A scholar is included among the top collaborators of Gianni Colotti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gianni Colotti. Gianni Colotti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Falvo, Elisabetta, Luciana Mosca, Alessandro Arcovito, et al.. (2024). Nose-to-brain selective drug delivery to glioma via ferritin-based nanovectors reduces tumor growth and improves survival rate. Cell Death and Disease. 15(4). 262–262. 27 indexed citations

Exertier, Cécile, et al.. (2024). Sorcin in Cancer Development and Chemotherapeutic Drug Resistance. Cancers. 16(16). 2810–2810.

Madia, Valentina Noemi, Cécile Exertier, Gianni Colotti, et al.. (2023). Inhibition of Leishmania infantum Trypanothione Reductase by New Aminopropanone Derivatives Interacting with the NADPH Binding Site. Molecules. 28(1). 338–338. 6 indexed citations

Fracasso, Giulio, Elisabetta Falvo, Gianluca Sala, et al.. (2023). Widespread in vivo efficacy of The-0504: A conditionally-activatable nanoferritin for tumor-agnostic targeting of CD71-expressing cancers. Heliyon. 9(10). e20770–e20770. 4 indexed citations

Narzi, Daniele, Theo Battista, Annarita Fiorillo, et al.. (2023). Investigation of the Entry Pathway and Molecular Nature of σ1 Receptor Ligands. International Journal of Molecular Sciences. 24(7). 6367–6367. 2 indexed citations

Battista, Theo, Stefano Federico, Simone Brogi, et al.. (2022). Optimization of Potent and Specific Trypanothione Reductase Inhibitors: A Structure-Based Drug Discovery Approach. ACS Infectious Diseases. 8(8). 1687–1699. 7 indexed citations

Marrocco, Ilaria, Flavia Giamogante, Maddalena Grieco, et al.. (2022). ERp57 chaperon protein protects neuronal cells from Aβ‐induced toxicity. Journal of Neurochemistry. 162(4). 322–336. 6 indexed citations

Fiorillo, Annarita, Veronica Morea, Gianni Colotti, & Andrea Ilari. (2021). Huntingtin Ubiquitination Mechanisms and Novel Possible Therapies to Decrease the Toxic Effects of Mutated Huntingtin. Journal of Personalized Medicine. 11(12). 1309–1309. 12 indexed citations

Battista, Theo, Gianni Colotti, Jessica Rosati, et al.. (2021). Known Drugs Identified by Structure-Based Virtual Screening Are Able to Bind Sigma-1 Receptor and Increase Growth of Huntington Disease Patient-Derived Cells. International Journal of Molecular Sciences. 22(3). 1293–1293. 5 indexed citations

10.

Battista, Theo, Antonino Missineo, Cristina Alli, et al.. (2020). Spiro-containing derivatives show antiparasitic activity against Trypanosoma brucei through inhibition of the trypanothione reductase enzyme. PLoS neglected tropical diseases. 14(5). e0008339–e0008339. 15 indexed citations

11.

Zwergel, Clemens, Manuela Sabatino, Gilbert Kirsch, et al.. (2020). Discovery of the First Human Arylsulfatase A Reversible Inhibitor Impairing Mouse Oocyte Fertilization. ACS Chemical Biology. 15(6). 1349–1357. 4 indexed citations

12.

Battista, Theo, et al.. (2020). Roles of Sorcin in Drug Resistance in Cancer: One Protein, Many Mechanisms, for a Novel Potential Anticancer Drug Target. Cancers. 12(4). 887–887. 31 indexed citations

13.

Battista, Theo, Gianni Colotti, Andrea Ilari, & Annarita Fiorillo. (2020). Targeting Trypanothione Reductase, a Key Enzyme in the Redox Trypanosomatid Metabolism, to Develop New Drugs against Leishmaniasis and Trypanosomiases. Molecules. 25(8). 1924–1924. 98 indexed citations

14.

Colotti, Gianni, Francesco Saccoliti, Marina Gramiccia, et al.. (2019). Structure-guided approach to identify a novel class of anti-leishmaniasis diaryl sulfide compounds targeting the trypanothione metabolism. Amino Acids. 52(2). 247–259. 17 indexed citations

15.

Ilari, Andrea, et al.. (2018). Toward a Drug Against All Kinetoplastids: From LeishBox to Specific and Potent Trypanothione Reductase Inhibitors. Molecular Pharmaceutics. 15(8). 3069–3078. 23 indexed citations

16.

Ilari, Andrea, Gianni Colotti, Theo Battista, et al.. (2018). Identification of chalcone-based antileishmanial agents targeting trypanothione reductase. European Journal of Medicinal Chemistry. 152. 527–541. 61 indexed citations

17.

Torrente, Esther, Antonino Missineo, M. Gramiccia, et al.. (2018). Identification and binding mode of a novel Leishmania Trypanothione reductase inhibitor from high throughput screening. PLoS neglected tropical diseases. 12(11). e0006969–e0006969. 51 indexed citations

18.

Saccoliti, Francesco, Luca Pescatori, Valentina Noemi Madia, et al.. (2017). Inhibition of Leishmania infantum trypanothione reductase by diaryl sulfide derivatives. Journal of Enzyme Inhibition and Medicinal Chemistry. 32(1). 304–310. 51 indexed citations

19.

Sechi, Stefano, Gianni Colotti, Giorgio Belloni, et al.. (2014). GOLPH3 Is Essential for Contractile Ring Formation and Rab11 Localization to the Cleavage Site during Cytokinesis in Drosophila melanogaster. PLoS Genetics. 10(5). e1004305–e1004305. 54 indexed citations

20.

Mozzarelli, Andrea, Stefano Bettati, Claudio Rivetti, et al.. (1996). Cooperative Oxygen Binding to Scapharca inaequivalvis Hemoglobin in the Crystal. Journal of Biological Chemistry. 271(7). 3627–3632. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact